Reaction

Metastases To Lymph Nodes reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 6,618 reports · 202 co-occurring drugs

As of the last recalculation, Metastases To Lymph Nodes appears in 6,618 FAERS reports alongside 202 co-occurring drug terms. The strongest observed disproportionality signal is ADO-TRASTUZUMAB EMTANSINE (PRR 59.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Ado-Trastuzumab Emtansine	156	59.6	60.7
Fulvestrant	454	46.3	47.0
Exemestane	276	42.2	42.8
Everolimus Tablets	194	37.5	37.9
Goserelin	146	34.9	35.3
Ribociclib	323	33.8	34.1
Letrozole	566	31.5	31.8
Lapatinib	151	31.3	31.6
Letrozole Tablets	442	30.9	31.2
Anastrozole Tablets	173	26.0	26.2
Docetaxel Anhydrous	503	25.3	25.5
Docetaxel	503	25.3	25.5
Bicalutamide	119	25.0	25.2
Pertuzumab	190	22.6	22.8
Everolimus	334	21.7	21.8
Anastrozole	243	21.6	21.7
Regorafenib	77	21.1	21.2
Trastuzumab	429	21.0	21.1
Capecitabine	549	20.5	20.6
Fam-Trastuzumab Deruxtecan-Nxki	58	18.2	18.3
Olaparib	117	17.9	18.0
Gefitinib	49	17.2	17.3
Bleomycin Sulfate	56	17.2	17.3
Paclitaxel (Aibumin-Bound)	403	16.4	16.4
Abiraterone	69	16.1	16.2
Panitumumab	78	15.8	15.9
Sorafenib	103	15.8	15.9
Gemcitabine	185	15.2	15.2
Paclitaxel	439	14.9	14.9
Zoledronic Acid	182	14.6	14.7
Dronabinol	36	14.2	14.2
Dabrafenib	93	14.1	14.1
Carboxymethylcellulose Sodium	41	13.8	13.9
Gemcitabine Hydrochloride	224	13.7	13.8
Trametinib	98	12.9	13.0
Irinotecan Hydrochloride	47	11.6	11.6
Temozolomide	74	11.2	11.2
Durvalumab	69	10.8	10.8
Doxorubicin Hydrochloride	108	10.6	10.6
Fluorouracil Cream, 0.5%	247	10.5	10.6
Octreotide Acetate	101	10.5	10.5
Pazopanib Hydrochloride	89	10.5	10.5
Fluorouracil	247	10.4	10.4
Cisplatin	244	10.2	10.2
Alpelisib	28	10.1	10.2
Niraparib	68	9.7	9.8
Carboplatin	372	9.7	9.7
Osimertinib	92	9.1	9.2
Conjugated Estrogens And Medroxyprogesterone Acetate	66	8.9	8.9
Sitagliptin And Metformin Hydrochloride	60	8.8	8.8
Fosaprepitant Dimeglumine	38	8.7	8.8
Ifosfamide	59	8.7	8.7
Bevacizumab	300	7.9	7.9
Sitagliptin	175	7.8	7.8
Doxorubicin	214	7.8	7.8
Oxaliplatin	177	7.7	7.7
Lanreotide Acetate	18	7.2	7.3
Erlotinib	22	7.2	7.2
Pemetrexed	48	7.1	7.1
Abiraterone Acetate	91	7.0	7.1
Atezolizumab	84	6.9	6.9
Aprepitant	40	6.8	6.9
Erlotinib Hydrochloride	26	6.6	6.6
Enzalutamide	120	6.5	6.5
Cetuximab	64	6.5	6.5
Denosumab	388	6.3	6.3
Anti-Thymocyte Globulin (Rabbit)	16	6.3	6.3
Leuprolide Acetate	151	6.2	6.3
Chlorhexidine Gluconate	18	6.2	6.2
Dexamethasone Sodium Phosphate	20	6.2	6.2
Leucovorin Calcium	37	6.1	6.1
Etoposide	138	6.0	6.0
Trazodone Hydrochloride	29	5.9	5.9
Cyclophosphamide Injection, Solution	316	5.8	5.9
Cyclophosphamide	316	5.8	5.9
Cyclophosphamide For Injection	316	5.8	5.9
Palbociclib	171	5.8	5.8
Pemetrexed Disodium	69	5.7	5.8
Filgrastim	66	5.6	5.6
Imatinib	30	5.4	5.4
Conjugated Estrogens	97	5.3	5.3
Estrogens, Conjugated	97	5.2	5.2
Granisetron	17	5.1	5.1
Medroxyprogesterone Acetate	80	5.1	5.1
Apalutamide	19	5.1	5.1
Exenatide	83	5.0	5.0
Vemurafenib	19	5.0	5.0
Mycophenilic Acid	32	4.9	4.9
Lactulose	59	4.9	4.9
Prochlorperazine Maleate	14	4.8	4.8
Sirolimus	20	4.7	4.7
Morphine	107	4.6	4.6
Ketoprofen	19	4.6	4.6
Granisetron Hydrochloride	15	4.5	4.5
Ipilimumab	61	4.5	4.5
Nivolumab	135	4.5	4.5
Relugolix	31	4.1	4.2
Cabozantinib	62	4.1	4.1
Lutetium Lu 177 Vipivotide Tetraxetan	17	4.1	4.1
Loperamide Hydrochloride Oral	13	4.0	4.0
Mometasone Furoate	50	3.8	3.8
Pioglitazone	51	3.7	3.7
Ondansetron	126	3.7	3.7
Ondansetron Tablets	126	3.7	3.7
Ondansetron Hydrochloride	141	3.7	3.7
Loperamide Hcl	15	3.7	3.7
Abemaciclib	23	3.6	3.6
Tacrolimus Ointment 0.1%	141	3.6	3.6
Tacrolimus Extended-Release Capsules	141	3.6	3.6
Prednisolone	196	3.5	3.5
Prednisolone Oral	196	3.5	3.5
Prednisolone Oral Solution	196	3.5	3.5
Fentanyl	108	3.5	3.5
Mycophenolic Acid	35	3.5	3.5
Rifampicin	11	3.4	3.4
Enoxaparin Sodium	61	3.4	3.4
Tacrolimus	164	3.4	3.4
Cephalexin	23	3.4	3.4
Mycophenolate Mofetil	141	3.3	3.3
Mycophenolate Mofetil Hydrochloride	141	3.3	3.3
Dalteparin Sodium	11	3.3	3.3
Magnesium Hydroxide	14	3.3	3.3
Adalimumab-Adaz	54	3.2	3.2
Cefepime Hydrochloride	16	3.1	3.1
Clindamycin	28	3.1	3.1
Ciprofloxacin Hydrochloride And Hydrocortisone	20	3.0	3.0
Diphenoxylate Hydrochloride And Atropine Sulfate	13	3.0	3.0
Imatinib Mesylate	26	2.9	2.9
Cefepime	13	2.9	2.9
Metoclopramide Hydrochloride	69	2.8	2.8
Terazosin Hydrochloride	8	2.8	2.8
Efavirenz	10	2.8	2.8
Adalimumab-Fkjp	41	2.8	2.8
Febuxostat Tablets 40 Mg	9	2.8	2.8
Febuxostat Tablets 80 Mg	9	2.8	2.8
Amphotericin B	11	2.8	2.8
Clindamycin Phosphate	29	2.7	2.7
Adalimumab-Aaty	41	2.7	2.7
Crizotinib	11	2.7	2.7
Losartan Potassium And Hydrochlorothiazide	10	2.7	2.7
Niacin	10	2.7	2.7
Ezetimibe And Simvastatin	13	2.7	2.7
Amoxicillin And Clavulanate Potassium	23	2.7	2.7
Cefazolin Sodium	10	2.6	2.6
Hydromorphone Hydrochloride	75	2.6	2.6
Levofloxacin	49	2.6	2.6
Levofloxacin In 5% Dextrose	49	2.6	2.6
Salmeterol Xinafoate	7	2.6	2.6
Liothyronine Sodium	7	2.5	2.5
Rucaparib	7	2.5	2.5
Fludarabine Phosphate	31	2.5	2.5
Metoclopramide	43	2.5	2.5
Lisinopril And Hydrochlorothiazide	8	2.5	2.5
Vitamin C	71	2.4	2.4
Pegfilgrastim	76	2.4	2.4
Bendamustine Hcl	12	2.4	2.4
Magnesium Oxide	32	2.4	2.4
Lisinopril And Hydrochlorothiazide Tablets	6	2.4	2.4
Valsartan Oral	41	2.4	2.4
Liraglutide	37	2.4	2.4
Progesterone	17	2.3	2.3
Melatonin	40	2.3	2.3
Ledipasvir And Sofosbuvir	14	2.3	2.3
Febuxostat	12	2.3	2.3
Encorafenib	7	2.2	2.2
Valsartan	73	2.2	2.2
Ursodiol	15	2.2	2.2
Raloxifene Hydrochloride	10	2.2	2.2
Ritonavir 100 Mg	10	2.1	2.1
Estradiol	57	2.1	2.1
Sunitinib Malate	26	2.1	2.1
Pembrolizumab	69	2.1	2.1
Trifluridine And Tipiracil	7	2.1	2.1
Glimepiride	25	2.0	2.0
Amlodipine Besylate And Valsartan	7	2.0	2.0
Estradiol Gel 0.1%	28	2.0	2.0
Estradiol Transdermal	28	2.0	2.0
Diclofenac Potassium, Film Coated	5	1.9	1.9
Diclofenac Potassium Tablets	5	1.9	1.9
Bendamustine Hydrochloride	7	1.8	1.8
Vincristine Sulfate	16	1.7	1.7
Pancrelipase	21	1.7	1.7
Thiotepa	5	1.6	1.6
Baricitinib	5	1.6	1.6
Entecavir	6	1.6	1.6
Interferon Beta-1A	93	1.5	1.5
Tolvaptan	7	1.5	1.5
Interferon Beta-1B	9	1.5	1.5
Diclofenac Potassium	5	1.5	1.5
Vedolizumab	39	1.4	1.4
Vismodegib	4	1.4	1.4
Guselkumab	16	1.4	1.4
Nintedanib	14	1.4	1.4
Secukinumab	69	1.3	1.3
Obinutuzumab	7	1.3	1.3
Morphine Sulfate	49	1.3	1.3
Axitinib	7	1.1	1.1
Suvorexant	4	1.0	1.0
Brexpiprazole	5	0.9	0.9
Lenvatinib	9	0.9	0.9
Methoxy Polyethylene Glycol-Epoetin Beta	3	0.9	0.9
Levonorgestrel	25	0.4	0.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.